Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAIL-induced signalling and apoptosis.

Marion MacFarlane1

  • 1MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE19HN, UK. mm21@le.ac.uk

Toxicology Letters
|March 12, 2003
PubMed
Summary

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in cancer cells but not normal cells. This study investigates TRAIL sensitivity and signaling pathways, exploring its potential for cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TREADS: tyre nanoparticles produced using a bench-top tyre wear simulator.

Environmental science. Nano·2026
Same author

Species-specific cleavage of the autophagy adaptor p62 dictates responses to TNF.

Molecular cell·2026
Same author

Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation.

Nature communications·2025
Same author

PAXX/Ku interaction is rate limiting for repair of double-strand DNA breaks requiring end processing.

The Journal of biological chemistry·2025
Same author

TAp73 regulates mitochondrial dynamics and multiciliated cell homeostasis through an OPA1 axis.

Cell death & disease·2024
Same author

An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy.

Scientific reports·2024

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Members of the tumor necrosis factor (TNF) family, including ligands and receptors, are key initiators of apoptosis.
  • TNF receptor family members possess a cytoplasmic 'death domain' (DD) crucial for signal transduction complex formation.
  • TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in tumor cells selectively, with low toxicity to normal cells, presenting a therapeutic opportunity.

Purpose of the Study:

  • To investigate the mechanisms underlying differential sensitivity to TRAIL-mediated apoptosis in tumor versus normal cells.
  • To explore the role of TRAIL-induced signaling pathways, including NF-kappaB activation and death inhibitors like c-FLIP, in determining TRAIL sensitivity.
  • To evaluate the potential of TRAIL as a therapeutic agent in cancer treatment.

Main Methods:

  • Analysis of TRAIL sensitivity in primary tumor cells.
  • Investigation of TRAIL-induced signaling pathways in both TRAIL-sensitive and TRAIL-resistant cell lines.
  • Examination of the expression and function of TRAIL receptors and intracellular death inhibitors.

Main Results:

  • Differential TRAIL sensitivity observed between primary tumor cells and normal tissues.
  • Identification of specific signaling pathways and molecular factors (e.g., NF-kappaB, c-FLIP) correlating with TRAIL sensitivity or resistance.
  • Evidence suggesting that factors beyond TRAIL receptor expression are critical for determining cellular response to TRAIL.

Conclusions:

  • TRAIL holds significant promise as a targeted cancer therapeutic due to its selective induction of apoptosis in tumor cells.
  • Understanding the complex TRAIL-induced signaling network is crucial for optimizing TRAIL-based cancer therapies.
  • Further research into TRAIL sensitivity mechanisms can lead to improved strategies for cancer treatment.

Related Experiment Videos